MARKET

URGN

URGN

Urogen Pharma
NASDAQ
28.18
+0.93
+3.41%
After Hours: 28.18 0 0.00% 17:29 06/09 EDT
OPEN
27.98
PREV CLOSE
27.25
HIGH
28.46
LOW
26.60
VOLUME
830.89K
TURNOVER
--
52 WEEK HIGH
32.37
52 WEEK LOW
6.64
MARKET CAP
1.37B
P/E (TTM)
-10.2652
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at URGN last week (0601-0605)?
Weekly Report · 1d ago
Guggenheim Remains a Buy on Urogen Pharma (URGN)
TipRanks · 6d ago
UroGen Buy Rating Reiterated as Teva Settlement Extends JELMYTO Exclusivity; $45 Price Target Maintained
TipRanks · 6d ago
UroGen, Teva Settle Jelmyto Patent Dispute, License Generic
TipRanks · 06/02 12:40
UroGen settles with Teva over Jelmyto patent dispute
Seeking Alpha · 06/02 12:36
UroGen Pharma Announces Settlement And License Agreement With Teva Pharmaceuticals Relating to JELMYTO
Benzinga · 06/02 12:02
Weekly Report: what happened at URGN last week (0525-0529)?
Weekly Report · 06/01 10:28
IBRX and the BCG Shortage: Deals That Could Expand Demand
NASDAQ · 05/29 17:29
More
About URGN
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

Webull offers Urogen Pharma Ltd stock information, including NASDAQ: URGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, URGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading URGN stock methods without spending real money on the virtual paper trading platform.